ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

A new chromatographic approach for the simultaneous determination of tramadol, ibuprofen, and caffeine in a novel fixed-dose combination tablet: an integrated framework to analytical sustainability and multimodal analgesia.

トラマドール、イブプロフェン、カフェインの新規配合錠における同時定量のための新しいクロマトグラフィー手法:分析の持続可能性と多剤併用鎮痛への統合的枠組み (機械翻訳の邦題)

BMC chemistry2025Wahba IA, Hassan SA, Fayed AS, et al.
研究デザインその他の原著論文
対象未確定

記録の確認項目

研究デザイン
その他の原著論文
対象
未確定
出版年
2025
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

多剤併用鎮痛のための新規配合錠中のトラマドール、イブプロフェン、カフェインを同時定量する初のHPLC法を開発・検証した。Zorbax SD-C8カラムを用い、アセトニトリルとリン酸緩衝液の移動相で8分以内に分離を達成した。直線性は各薬物で1.0-45.0、1.0-25.0、1.0-30.0 µg/mLであり、精度はRSD 2%未満、回収率は100.42-100.82%と良好だった。ICHガイドラインに従いバリデーションを行い、原薬、混合粉末、製剤に適用した。さらに、分析法の持続可能性を複数のグリーンケミストリーメトリクスで評価し、高い実用性と環境適合性を示した。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Multimodal analgesia and rational polypharmacy have emerged as modern pain management strategies, offering synergistic pain relief while mitigating the adverse effects of high-dose monotherapy. A novel antinociceptive fixed-dose combination tablet containing tramadol, ibuprofen, and caffeine exemplifies this approach by integrating a centrally acting weak opioid tramadol, a peripherally acting nonsteroidal anti-inflammatory drugs ibuprofen, and a central nervous system stimulant adjuvant caffeine into a single formulation. In the present work, the first HPLC method for the concurrent quantification of tramadol, ibuprofen and caffeine in bulk powder and tablet dosage forms was developed and validated to support the quality control of this innovative multimodal analgesic fixed-dose combination. The optimal chromatographic separation was achieved using a Zorbax SD-C8 column (150 × 4.6 mm, 5 µm) as the stationary phase. The mobile phase was composed of acetonitrile: 0.01 M phosphate buffer pH 5.0 (35.0: 65.0, v/v), delivered at a flow rate of 1.0 mL/min with UV detection at 220.0 nm. The separation was achieved within 8.0 min, with linearity ranges of 1.0-45.0 μg/mL for tramadol, 1.0-25.0 μg/mL for ibuprofen, and 1.0-30.0 µg/mL for caffeine. The suggested method was validated according to the ICH guidelines and successfully utilized for the quantitative determination of tramadol, ibuprofen and caffeine in bulk powder, laboratory-prepared mixtures and pharmaceutical formulation. The proposed method exhibited outstanding performance for determination of the three cited drugs, characterized by high accuracy (ranging from 100.42% to 100.82%) and excellent precision (< 2% RSD). The sustainability profile of the method was assessed using the Analytical eco-scale, Analytical GREEnness metric, Green analytical procedure index, Blue Applicability Grade Index, White analytical chemistry, and Violet Innovation Grade Index to evaluate the sustainability, applicability, and innovative potential of the proposed method. The method combines analytical rigor, operational simplicity, and sustainable design, setting a new benchmark for analytical support of rational polypharmacy products.

DOI 10.1186/s13065-025-01688-8

PMID 41392265

原文・出典を見る →